Acute treatment of hyperammonemia by continuous renal replacement therapy in a newborn patient with ornithine transcarbamylase deficiency |
Kim, Hyo-Jeong
(The Institute of Kidney Disease, Department of Pediatrics, Yonsei University College of Medicine)
Park, Se-Jin (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine) Park, Kook-In (The Institute of Kidney Disease, Department of Pediatrics, Yonsei University College of Medicine) Lee, Jin-Sung (Department of Clinical Genetics, Yonsei University College of Medicine) Eun, Ho-Sun (The Institute of Kidney Disease, Department of Pediatrics, Yonsei University College of Medicine) Kim, Ji-Hong (The Institute of Kidney Disease, Department of Pediatrics, Yonsei University College of Medicine) Shin, Jae-Il (The Institute of Kidney Disease, Department of Pediatrics, Yonsei University College of Medicine) |
1 | Snyderman SE. Clinical aspects of disorders of the urea cycle. Pediatrics 1981;68:284-289, 295-297. |
2 | Leonard JV. Urea cycle disorders. In: Fernandes J, Saudubray JM, Van den Berghe G, editors. Inborn metabolic diseases: diagnosis and treatment. 2nd ed. Berlin: Springer-Verlag, 1995:167-76. |
3 | Lindgren V, de Martinville B, Horwich AL, Rosenberg LE, Francke U. Human ornithine transcarbamylase locus mapped to band Xp21.1 near the Duchenne muscular dystrophy locus. Science 1984;226:698-700. DOI |
4 | Hata A, Tsuzuki T, Shimada K, Takiguchi M, Mori M, Matsuda I. Structure of the human ornithine transcarbamylase gene. J Biochem 1988;103:302-308. DOI |
5 | Maddalena A, Spence JE, O'Brien WE, Nussbaum RL. Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. J Clin Invest 1988;82:1353-1358. DOI |
6 | Maestri NE, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis. J Pediatr 1999;134:268-272. DOI ScienceOn |
7 | Matsuda I, Nagata N, Matsuura T, Oyanagi K, Tada K, Narisawa K, et al. Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency. Am J Med Genet 1991;38:85-89. DOI ScienceOn |
8 | Tuchman M, Morizono H, Rajagopal BS, Plante RJ, Allewell NM. The biochemical and molecular spectrum of ornithine transcarbamylase deficiency. J Inherit Metab Dis 1998;21 Suppl 1:40-58. DOI |
9 | Mathias RS, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 2001;37:1069-1080. DOI ScienceOn |
10 | Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996;43:127-170. |
11 | Brusilow SW. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis. J Clin Invest 1984;74:2144-148. DOI |
12 | Donn SM, Swartz RD, Thoene JG. Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 1979;95:67-70. DOI |
13 | Falk MC, Knight JF, Roy LP, Wilcken B, Schell DN, O'Connell AJ, et al. Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol 1994;8:330-333. DOI ScienceOn |
14 | Wiegand C, Thompson T, Bock GH, Mathis RK, Kjellstrand CM, Mauer SM. The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 1980;96:142-144. DOI |
15 | Arbeiter AK, Kranz B, Wingen AM, Bonzel KE, Dohna-Schwake C, Hanssler L, et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010;25:1257-1265. DOI ScienceOn |
16 | Wong KY, Wong SN, Lam SY, Tam S, Tsoi NS. Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 1998;12:589-591. DOI ScienceOn |
17 | Picca S, Dionisi-Vici C, Abeni D, Pastore A, Rizzo C, Orzalesi M, et al. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 2001;16:862-867. DOI ScienceOn |
18 | Hmiel SP, Martin RA, Landt M, Levy FH, Grange DK. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration. Pediatr Crit Care Med 2004;5:278-281. DOI ScienceOn |